Analyst Price Targets — VINC
Page 1 • Showing up to 10
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 8, 2024 9:39 am | Jonathan Chang | Leerink Partners | $2.00 | $0.58 | TheFly | Vincerx Pharma price target lowered to $2 from $4 at Leerink |
| June 7, 2022 2:11 pm | Matthew Barcus | Chardan Capital | $4.00 | $1.98 | Benzinga | Analysts Cuts Price Target On This Small Cap But Remain Bullish |
×
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
No recent news available for VINC.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VINC.
U.S. House Trading
No House trades found for VINC.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
